Back to search

Article

Molecular determinants associated with resistance to imipenem and imipenem–relebactam in clinical Pseudomonas aeruginosa isolates

2025-11-04

Abstract excerpt

<title>Abstract</title> <p> Background <italic>Pseudomonas aeruginosa</italic> accounts for 10–20% of hospital-acquired infections and is a major pathogen in immunocompromised patients. Combination therapies with beta-lactam antibiotics and beta-lactamase inhibitors, such as imipenem-relebactam have improved treatment options, yet resistant strains have already emerged, with mechanisms still not fully elucidat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8501ed0f-1962-5adf-9bf6-b71bf6f2ef04
DOI
10.21203/rs.3.rs-7801871/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Molecular determinants associated with resistance to imipenem and imipenem–relebactam in clinical Pseudomonas aeruginosa isolatesDOI 10.21203/rs.3.rs-7801871/v1
Select a neighboring publication to make it the new centre.